West Marine Inc (WMAR)

12.93
NASDAQ : Services
Prev Close 12.92
Day Low/High 12.90 / 12.93
52 Wk Low/High 7.77 / 13.01
Avg Volume 189.60K
Exchange NASDAQ
Shares Outstanding 25.27M
Market Cap 326.55M
EPS 0.20
P/E Ratio 41.68
Div & Yield 0.20 (1.50%)

Latest News

Income Seeker: Happy Early Returns From This Value-Oriented Dividend Portfolio

Jonathan Heller reports on his Double-Net Dividend portfolio, a mix of companies trading cheaply relative to net current assets that also return cash to shareholders.

Happy Early Returns From This Value-Oriented Dividend Portfolio

Happy Early Returns From This Value-Oriented Dividend Portfolio

Just two months after its creation, the portfolio handily is beating the Russell 2000 Index and Russell Microcap Index.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Concerning Whether The Sale Of West Marine, Inc. To Monomoy Capital Partners Is Fair To Shareholders

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Concerning Whether The Sale Of West Marine, Inc. To Monomoy Capital Partners Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased West Marine, Inc.

My Midyear Value Investing Highs and Lows

My Midyear Value Investing Highs and Lows

Bob Evans Farms and Kulicke & Soffa were among the first-half winners, while Ruby Tuesday and Fitbit were big disappointments.

Biotech Movers: Immuno-Oncology Pact With Celgene Sends BeiGene Shares Soaring

Biotech Movers: Immuno-Oncology Pact With Celgene Sends BeiGene Shares Soaring

BeiGene and Impax Laboratories were among the biotech movers in premarket trading on July 6.

This Biotech Stock Is Surging More Than 20% Today

This Biotech Stock Is Surging More Than 20% Today

Here are the names.

Biotech Movers: BioCryst, Omeros, Radius Health

Biotech Movers: BioCryst, Omeros, Radius Health

BioCryst Pharmaceuticals, Omeros and Radius Health were among the were among the biotech stock movers in premarket trading on July 3.

Who's Next? 4 Cash-Rich Names With 'Net' Positives

Who's Next? 4 Cash-Rich Names With 'Net' Positives

'Double-nets' have been fertile ground for acquisitions.

Pharma Firms Hit With Lawsuit From Oklahoma AG Over Opioid Marketing

Pharma Firms Hit With Lawsuit From Oklahoma AG Over Opioid Marketing

Oklahoma Attorney General Mike Hunter alleged that the firms engaged in misleading marketing practices and "waged a fraudulent, decade-long marketing campaign to profit from the anguish of thousands of Oklahomans."

Biotech Movers: Paratek, Opko, Endo

Biotech Movers: Paratek, Opko, Endo

Shares of Paratek Pharmaceuticals, Opko Health and Endo International were among the biotech stock movers in premarket trading on June 30.

West Marine Reaches Analyst Target Price

In recent trading, shares of West Marine, Inc. have crossed above the average analyst 12-month target price of $9.67, changing hands for $9.75/share.

West Marine Becomes Oversold (WMAR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Income Seeker: The Search for the Elusive Double-Net Dividend Payers

One might think that companies trading cheaply would not be dividend payers. But that’s not the case.

Movado and 9 Other Deep-Value Dividend Payers Worth Watching

Movado and 9 Other Deep-Value Dividend Payers Worth Watching

The list is dominated by retailers, of which there are four; that's unfortunate, given the pressure that sector is facing these days.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALOT, BOOM, BWA, DAR, EHTH, ESRT, ETR, FNGN, FOE, FPO, FSS, GGG, KKR, KRA, MSCC, TOT, TZOO, WMAR Downgrades: BABY, CREG, DEPO, ETH, EXPE, GNRC, SPOK, TDC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

West Marine Reaches Analyst Target Price

In recent trading, shares of West Marine, Inc. have crossed above the average analyst 12-month target price of $9.67, changing hands for $9.83/share.

West Marine Dividend Causes a Splash

West Marine Dividend Causes a Splash

I've never seen such a small name that is so deep into value territory begin paying a dividend.

West Marine Surprisingly Launches Dividend

West Marine Surprisingly Launches Dividend

I've never seen such a small name that is so deep into value territory begin paying a dividend.

Using an Old Screen to Shift Through Value Names and Find a Few Nuggets

Using an Old Screen to Shift Through Value Names and Find a Few Nuggets

This screen looks to identify companies that may be cheap based on measures of earnings and book value.